Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Anhui Medical University is the lead sponsor of 30 current clinical trials in our China register. 14 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Abiraterone, All-trans retinoic acid and Arsenic Trioxide. The most-studied condition is Parkinson Disease.

ClinicalTrials.gov trials by status

Recruiting1447%
Not yet open827%
Active, closed517%
By invitation310%

Trials by phase

Not applicable2170%
Observational620%
Phase 227%
Phase EARLY_PHASE113%

Clinical trials sponsored by Anhui Medical University

30 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease NCT07118956 · ClinicalTrials.gov ↗ · Parkinson Disease, Apathy, Non-motor Symptoms	Not applicable	Recruiting	2025-05	China
Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury NCT07486804 · ClinicalTrials.gov ↗ · Non-suicidal Self-injury	Not applicable	Recruiting	2025-10	China
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study NCT06336174 · ClinicalTrials.gov ↗ · Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event	Observational	Recruiting	2022-11	China
Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial NCT07656805 · ClinicalTrials.gov ↗ · T2DM (Type 2 Diabetes Mellitus)	Not applicable	Recruiting	2026-06	China
Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder NCT07330648 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder Drugs: Crisugabalin, Venlafaxine	Phase 2	Recruiting	2025-10	China
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait NCT05192759 · ClinicalTrials.gov ↗ · Transcranial Magnetic Stimulation, Freezing of Gait	Not applicable	Recruiting	2021-11	China
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease NCT06383247 · ClinicalTrials.gov ↗ · Parkinson Disease, Transcranial Magenetic Stimualtion, Supplementary Motor Area	Not applicable	Recruiting	2024-12	China
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B NCT05922306 · ClinicalTrials.gov ↗ · Hepatitis B, Chronic	Phase EARLY_PHASE1	Recruiting	2023-07	China
The Impact of Beta-band Transcranial Alternating Current Stimulation (tACS) on Impulse Inhibition in Adolescents With Non-suicidal Self-injury NCT07152925 · ClinicalTrials.gov ↗ · Depression Disorders, Non-suicidal Self-injury	Not applicable	Recruiting	2025-03	China
Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China NCT07053657 · ClinicalTrials.gov ↗ · Cardiometabolic Risk Factors	Not applicable	Recruiting	2025-09	China
Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis NCT07112599 · ClinicalTrials.gov ↗ · Prostate Cancer, Lymph Node Cancer Metastatic, Artificial Intelligence (AI)	Observational	Recruiting	2026-01	China
Personalized iTBS in Real-World Clinical Settings for Schizophrenia NCT07176468 · ClinicalTrials.gov ↗ · Schizophrenia, Transcranial Magnetic Stimulation	Not applicable	Recruiting	2025-10	China
Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial NCT07827196 · ClinicalTrials.gov ↗ · Transcranial Random Noise Stimulation (tRNS), Electroencephalography, Alzheimer Disease	Not applicable	Recruiting	2026-09	China
Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI) NCT06127056 · ClinicalTrials.gov ↗ · Transcranial Alternating Current Stimulation, Non-suicidal Self-injury	Not applicable	Recruiting	2023-05	China
Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer NCT07818421 · ClinicalTrials.gov ↗ · Prostate Cancer Adenocarcinoma	Observational	Not yet open	2026-10	China
Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder NCT07403591 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder	Not applicable	Not yet open	2026-03	China
The Impact of One-Year Boxing Training on Attention in Adolescent Athletes NCT07688616 · ClinicalTrials.gov ↗ · Attention, Healthy Volunteers	Not applicable	Not yet open	2026-07	China
The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD NCT06607653 · ClinicalTrials.gov ↗ · Parkinson Disease, Olfactory Disorder, Olfactory Training	Not applicable	Not yet open	2024-09	China
Network-Guided Individualized TMS for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial NCT07692542 · ClinicalTrials.gov ↗ · Transcranial Magnetic Stimulation, Behavioral and Psychological Symptoms in Alzheimer's Disease, Individualized Navigation	Not applicable	Not yet open	2026-07	China
Spatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer NCT07818395 · ClinicalTrials.gov ↗ · Prostate Cancer Adenocarcinoma	Observational	Not yet open	2026-10	China
A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer. NCT07795177 · ClinicalTrials.gov ↗ · Metastatic Hormone-Sensitive Prostate Cancer Drug: Abiraterone	Phase 2	Not yet open	2026-10	China
Development and Pilot Application of a Solution-Focused Intervention for Social Isolation in Elderly Diabetic Foot Patients NCT07787884 · ClinicalTrials.gov ↗ · Diabetic Foot Disease	Not applicable	Not yet open	2026-08	China
Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases NCT06450964 · ClinicalTrials.gov ↗ · Mitochondrial Diseases	Observational	By invitation	2024-09	China
Daunorubicin + Cytarabine + Venetoclax in de Novo AML NCT06697327 · ClinicalTrials.gov ↗ · Leukemia, Myeloid, Acute, Acute Myeloid Leukemia	Not applicable	By invitation	2025-02	China
A Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease NCT06642454 · ClinicalTrials.gov ↗ · Parkinson Disease, Apathy, Sleep Disorder	Not applicable	By invitation	2024-10	China
Health Coaching for Self-Management in Maintenance Hemodialysis Patients NCT07685626 · ClinicalTrials.gov ↗ · End-Stage Kidney Disease (ESKD), Maintenance Hemodialysis (MHD)	Not applicable	Active, closed	2026-03	China
The Ma'Anshan Birth Cohort (MABC) NCT03215368 · ClinicalTrials.gov ↗ · Environmental Exposure, Pregnancy Outcome, Birth Defects	Observational	Active, closed	2013-05	China
Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors NCT07083518 · ClinicalTrials.gov ↗ · Transcranial Direct Current Stimulation (tDCS), Breast Cancer Survivor, Cognitive Impairment	Not applicable	Active, closed	2025-05	China
Neuroimage-guided Dual-target Continuous Theta Burst Stimulation for Generalized Anxiety Disorder NCT06699706 · ClinicalTrials.gov ↗ · Anxiety, Transcranial Magnetic Stimulation Repetitive	Not applicable	Active, closed	2024-11	China
Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia NCT07187505 · ClinicalTrials.gov ↗ · Acute Promyelocytic Leukemia (APL) Drugs: All-trans retinoic acid, Arsenic Trioxide, Tretinoin	Not applicable	Active, closed	2025-07	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Anhui Medical University trials

7 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Abiraterone1 All-trans retinoic acid1 Arsenic Trioxide1 Crisugabalin1 Tretinoin1 Venetoclax1 Venlafaxine1

Conditions in Anhui Medical University trials

51 conditions

Parkinson Disease4Non-suicidal Self-injury3Transcranial Magnetic Stimulation3Prostate Cancer Adenocarcinoma2Apathy2Cognitive Impairment2 Generalized Anxiety Disorder2Non-motor Symptoms1Vagus Nerve Stimulation1End-Stage Kidney Disease (ESKD)1Maintenance Hemodialysis (MHD)1Intracranial Atherosclerosis1Cerebrovascular Event1Environmental Exposure1Pregnancy Outcome1Birth Defects1Child Development1T2DM (Type 2 Diabetes Mellitus)1Attention1Healthy Volunteers1Freezing of Gait1Olfactory Disorder1Olfactory Training1Transcranial Magenetic Stimualtion1

By trial register

Register	Trials	Recruiting
Clinical trials in China	30	14

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Parkinson Disease

Sponsor	Trials
Xiangya Hospital of Central South University	7
InSightec	2
iRegene Therapeutics	2
AskBio	1
BlueRock Therapeutics	1

Sponsors with the most current trials registered for this condition.

Questions about Anhui Medical University trials

How many clinical trials does Anhui Medical University sponsor?

Anhui Medical University is the lead sponsor of 30 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Anhui Medical University trials recruiting?

Yes. 14 of its 30 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Anhui Medical University testing?

Its current trials name 7 drugs and biologicals as interventions. The most frequent are Abiraterone (1), All-trans retinoic acid (1), Arsenic Trioxide (1), Crisugabalin (1) and Tretinoin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Anhui Medical University clinical trials